Skip to main content
. 2020 Aug 26;10:1538. doi: 10.3389/fonc.2020.01538

Figure 1.

Figure 1

The trend of white blood cell count, absolute peripheral blasts, and platelet and timelines of introduction of sorafenib for patient 1 (A) and patient 2 (B) are presented. Abbreviations: WBC, white blood cell, ABS BL, absolute blasts, PLT, platelets, S800 (sorafenib 800 mg daily), AZA 3 (azacitidine 75 mg/m2 Day 1–3 each cycle), AZA 5 (azacitidine 75 mg/m2 Day 1–3 each cycle), M, mutational profiling, S400 (sorafenib 400 mg daily).